investor.generalmoly.com
General Moly : Investor Relations : Corporate Overview
Transfer Agents and Services. Quarterly Reports and Webcasts. General Moly at Jefferies 2015 Industrials Conference. 160;at 10:40 am ET. General Moly at Jefferies 2015 Industrials Conference. Wednesday, August 12, 2015 . 10:40 am ET . Click here for webcast. Â Click here to add this event to your calendar. Most Recent Corporate Presentation. Annual Meeting of Stockholders Presentation. General Moly to Attend the Jefferies Industrials Conference. General Moly Announces Second Quarter 2015 Results.
investor.generex.com
Generex Biotechnology Corporation - Investor Home
Large Molecule Drugs Challenge. Jun 24, 2015. Generex Announces Capital Investment. May 26, 2015. Generex Announces Collaboration with NHTherapeutics to Utilize the RapidMist™ Buccal Delivery Technology for Leuprolide. May 14, 2015. Generex Provides Data Update from AE37 Phase II Breast Cancer Trial One Year Post Completion of Enrollment. Raquo; Investor Home. For more information please contact:. 44 West Lancaster Avenue. Ardmore, PA 19003. Eckert Seamans Cherin and Mellott, LLC. Philadelphia, PA 19102.
investor.genomichealth.com
Investors | Genomic Health, Inc.
United States - English. United States - English. United Kingdom - English. Genomic Health is the world's leading provider of genomic-based diagnostic tests that address both the overtreatment and optimal treatment of early-stage cancer, one of the greatest issues in healthcare today. Company Timeline and Milestones. Genomic Health and Oncotype IQ - Delivering Precision Medicine. Watch how Genomic Health continues to transform cancer care around the world. World Class Commercial Channel. Watch CEO Kim Po...
investor.genoptix.com
Genoptix Medical Laboratory - Company Information
Genoptix is a leading specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to its physician customers, community-based hematologists and oncologists. On the forefront of personalized diagnostic services, Genoptix’s highly trained group of hematopathologists utilize sophisticated technology to provide integrated testing and actionable diagnostic reports. Its diagnostic services are designed to optimize the care of patients suffering...
investor.genovis.com
Genovis Investor Relations » Investor Relations
Fem år i sammandrag. Val av styrelse / valberedning. Ändr: -0.04 (-1.44%) / Köp: 2.73 / Sälj: 2.77 / Senast: 2.73 / Högst: 2.75 / Lägst: 2.71 / Antal: 14920 / Oms.: 40656 / Valuta: SEK / 2017-01-13 16:51 (CET). GENOVIS BYTER CERTIFIED ADVISER. Genovis har tecknat licensavtal med Life Technologies Corporation. Genovis och Promega har ingått förlikning och tecknat ett globalt licensavtal. ÖKAD FÖRSÄLJNING OCH KRAFTIGT FÖRBÄTTRAT RESULTAT. HALVÅRSRAPPORT JANUARI JUNI 2016. Tel: 46 46 10 12 30.
investor.genworth.com
Genworth Financial - Investors
Stock Quote and Chart. Stock Purchase / Dividend Reinvestment. Dividends and Stock Splits. Code of Business Conduct and Ethics. Political Contributions and Expenditures. 2017 Annual Meeting Of Stockholders Results. 2017 Special Meeting Of Stockholders Results. Welcome to Genworth Investor Relations. Genworth remains committed to helping families become more financially secure, self-reliant and prepared for the future. Genworth 4Q17 Earning Summary Presentation (Feb 7). View all press releases.
investor.genworth.com.au
Genworth - Investor Centre
About Genworth and LMI. What is Lenders Mortgage Insurance? How can Lenders Mortgage Insurance benefit me? Lenders Mortgage Insurance FAQs. Lenders Mortgage Insurance endorsements. Partnership and Distribution team. Genworth in the community. Investor and international news. MFAA National Convention 2015. Share price and tools. Share price and graph. Online tools, forms and reports. LMI Proposal and Variation Requests. Homeowner Assistance Program (HOAP). Policy and process information. How to sell LMI.
investor.genworthmicanada.ca
Genworth MI Canada - Home
Feb 7, 2018 10:30 AM ET. Q4 REPORT NOW AVAILABLE. December 6, 2017. Annual General Meeting of Shareholders. June 8, 2017 10:00am ET. Education and Financial Literacy. Community and Civic Responsibility. Compensation and Nominating Committee. Risk, Capital and Investment Committee. PANEL 1: Driving Core Growth. PANEL 2: Proactively Mitigating Risk. PANEL 3: Sustaining Profitability. March 5, 2018 -. National Meaning of Home youth writing contest raises $170,000 for Habitat for Humanity. February 6, 2018 -.
investor.ggp.com
GGP Investor Center
Kiosks, Carts and Specialty Leasing. GGP in the Community. Properties keyboard arrow right. Leasing keyboard arrow right. Kiosks, Carts and Specialty Leasing. Advertising keyboard arrow right. Investors keyboard arrow right. About GGP keyboard arrow right. GGP in the Community. GGP’s mission is to own and operate best-in-class retail properties that provide an outstanding environment and experience for our communities, retailers, employees, consumers and shareholders. View our latest Investor Presentation.
investor.gidynamics.com
GIDynamics, Inc. - Investors
Skip to main content. GI Dynamics, Inc. Company Overview. GI Dynamics, Inc. (ASX:GID) is the developer of EndoBarrier, the first endoscopically-delivered device approved for the treatment of type 2 diabetes and obesity. EndoBarrier is not approved for sale in the United States and is limited by federal law to investigational use only in the United States. Founded in 2003, GI Dynamics is headquartered in Boston, Massachusetts. Enter the code shown above. Email Alert Sign Up Confirmation. Boston, MA 02210.
investor.gigatronics.com
Giga-tronics Incorporated (GIGA)
Advanced Signal Generator Module. Advanced Signal Analyzer Module. Real-Time Threat Emulation System. Advanced Signal Control Software Suite. Consider Build vs Buy your next EW / Radar test system? Call us 1 925 328 4650. Advanced Signal Generator Module. Advanced Signal Analyzer Module. Real-Time Threat Emulation System. Advanced Signal Control Software Suite. Feb 12, 2018 4:02 PM EST. Q3 2018 Quarterly Results. Quarter Ended Dec 30, 2017. Mar 26, 2018. Quarter Ended Dec 30, 2017. View Board of Directors.
